Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations
- PMID: 34202022
- PMCID: PMC8306581
- DOI: 10.3390/md19070367
Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations
Abstract
Nicotinic acetylcholine receptor (nAChR) subtypes are key drug targets, but it is challenging to pharmacologically differentiate between them because of their highly similar sequence identities. Furthermore, α-conotoxins (α-CTXs) are naturally selective and competitive antagonists for nAChRs and hold great potential for treating nAChR disorders. Identifying selectivity-enhancing mutations is the chief aim of most α-CTX mutagenesis studies, although doing so with traditional docking methods is difficult due to the lack of α-CTX/nAChR crystal structures. Here, we use homology modeling to predict the structures of α-CTXs bound to two nearly identical nAChR subtypes, α3β2 and α3β4, and use free-energy perturbation (FEP) to re-predict the relative potency and selectivity of α-CTX mutants at these subtypes. First, we use three available crystal structures of the nAChR homologue, acetylcholine-binding protein (AChBP), and re-predict the relative affinities of twenty point mutations made to the α-CTXs LvIA, LsIA, and GIC, with an overall root mean square error (RMSE) of 1.08 ± 0.15 kcal/mol and an R2 of 0.62, equivalent to experimental uncertainty. We then use AChBP as a template for α3β2 and α3β4 nAChR homology models bound to the α-CTX LvIA and re-predict the potencies of eleven point mutations at both subtypes, with an overall RMSE of 0.85 ± 0.08 kcal/mol and an R2 of 0.49. This is significantly better than the widely used molecular mechanics-generalized born/surface area (MM-GB/SA) method, which gives an RMSE of 1.96 ± 0.24 kcal/mol and an R2 of 0.06 on the same test set. Next, we demonstrate that FEP accurately classifies α3β2 nAChR selective LvIA mutants while MM-GB/SA does not. Finally, we use FEP to perform an exhaustive amino acid mutational scan of LvIA and predict fifty-two mutations of LvIA to have greater than 100X selectivity for the α3β2 nAChR. Our results demonstrate the FEP is well-suited to accurately predict potency- and selectivity-enhancing mutations of α-CTXs for nAChRs and to identify alternative strategies for developing selective α-CTXs.
Keywords: conotoxin; free-energy perturbation; nicotinic acetylcholine receptor; selectivity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Basic Residues at Position 11 of α-Conotoxin LvIA Influence Subtype Selectivity between α3β2 and α3β4 Nicotinic Receptors via an Electrostatic Mechanism.ACS Chem Neurosci. 2023 Dec 20;14(24):4311-4322. doi: 10.1021/acschemneuro.3c00506. Epub 2023 Dec 5. ACS Chem Neurosci. 2023. PMID: 38051211
-
A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.FASEB J. 2014 Apr;28(4):1842-53. doi: 10.1096/fj.13-244103. Epub 2014 Jan 7. FASEB J. 2014. PMID: 24398291 Free PMC article.
-
Key residues in the nicotinic acetylcholine receptor β2 subunit contribute to α-conotoxin LvIA binding.J Biol Chem. 2015 Apr 10;290(15):9855-62. doi: 10.1074/jbc.M114.632646. Epub 2015 Feb 20. J Biol Chem. 2015. PMID: 25713061 Free PMC article.
-
Mutagenesis of α-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors.Toxins (Basel). 2019 Feb 13;11(2):113. doi: 10.3390/toxins11020113. Toxins (Basel). 2019. PMID: 30781866 Free PMC article. Review.
-
The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.Curr Top Med Chem. 2015;16(2):156-69. doi: 10.2174/1568026615666150701114831. Curr Top Med Chem. 2015. PMID: 26126912 Review.
Cited by
-
The maximal and current accuracy of rigorous protein-ligand binding free energy calculations.Commun Chem. 2023 Oct 14;6(1):222. doi: 10.1038/s42004-023-01019-9. Commun Chem. 2023. PMID: 37838760 Free PMC article.
-
Marine Drug Discovery through Computer-Aided Approaches.Mar Drugs. 2023 Aug 17;21(8):452. doi: 10.3390/md21080452. Mar Drugs. 2023. PMID: 37623733 Free PMC article.
-
Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications.Biomolecules. 2022 Jan 23;12(2):189. doi: 10.3390/biom12020189. Biomolecules. 2022. PMID: 35204690 Free PMC article. Review.
-
Alchemical Free Energy Calculations to Investigate Protein-Protein Interactions: the Case of the CDC42/PAK1 Complex.J Chem Inf Model. 2022 Jun 27;62(12):3023-3033. doi: 10.1021/acs.jcim.2c00348. Epub 2022 Jun 9. J Chem Inf Model. 2022. PMID: 35679463 Free PMC article.
-
In Silico Conotoxin Studies: Progress and Prospects.Molecules. 2024 Dec 23;29(24):6061. doi: 10.3390/molecules29246061. Molecules. 2024. PMID: 39770149 Free PMC article. Review.
References
-
- Romero H.K., Christensen S.B., Di Cesare Mannelli L., Gajewiak J., Ramachandra R., Elmslie K.S., Vetter D.E., Ghelardini C., Iadonato S.P., Mercado J.L., et al. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain. Proc. Natl. Acad. Sci. USA. 2017;114:E1825–E1832. doi: 10.1073/pnas.1621433114. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources